Abstract
Purpose
Radio-resistance is recognized as a main factor in the failure of radiotherapy in oesophageal squamous cell carcinoma (ESCC). Aberrant cell surface glycosylation has been reported to correlate with radio-resistance in different kinds of tumours. However, glycomic alterations and the corresponding enzymes associated with ESCC radio-resistance have not yet been defined.
Methods
Two radioresistant cell lines, EC109R and TE-1R, were established from parental ESCC cell lines EC109 and TE-1 by fractionated irradiation. A lectin microarray was used to screen for altered glycan patterns. RNA-sequencing (RNA-seq) was employed to identify differentially expressed glycosyltransferases. Cell Counting Kit-8, colony formation and flow cytometry assays were used to measure cell viability and radiosensitivity. Expression of glycosyltransferase in ESCC tissues was assessed by immunohistochemistry. In vivo radiosensitivity was analysed using a nude mouse xenograft model. Downstream effectors of the enzyme were verified using a lectin-based pull-down assay combined with mass spectrometry.
Results
We found that EC109R and TE-1R cells were more resistant to irradiation than the parental EC109 and TE-1 cells. Using lectin microarrays combined with RNA sequencing, we found that α1, 6-fucosyltransferase (FUT8) was overexpressed in the radioresistant ESCC cell lines. Both gain- and loss-of-function studies confirmed that FUT8 regulates the sensitivity of ESCC cells to irradiation. Importantly, we found that high FUT8 expression was positively linked to radio-resistance and a poor prognosis in ESCC patients who received radiation therapy. Moreover, FUT8 inhibition suppressed the growth and formation of xenograft tumours in nude mice after irradiation. Using a lectin-based pull-down assay and mass spectrometry, we found that CD147 could be glycosylated by FUT8. As expected, inhibition of CD147 partly reversed FUT8-induced radio-resistance in ESCC cells.
Conclusions
Our results indicate that FUT8 functions as a driver of radio-resistance in ESCC by targeting CD147. Therefore, FUT8 may serve as a marker for predicting the response to radiation therapy in patients with ESCC.
Similar content being viewed by others
References
R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018)
A. Fatehi Hassanabad, R. Chehade, D. Breadner, J. Raphael. Esophageal carcinoma: Towards targeted therapies. Cell. Oncol. 43, 195–209 (2020)
X. Sun, R.G.C. Martin, Q. Zheng, R. Farmer, H. Pandit, X. Li, K. Jacob, J. Suo, Y. Li, Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma. Cell. Oncol. 41, 651–662 (2018)
H. Zeng, R. Zheng, S. Zhang, T. Zuo, C. Xia, X. Zou, W. Chen, Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries. Thorac. Cancer 7, 232–237 (2016)
W. Chen, R. Zheng, P.D. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X.Q. Yu, J. He, Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115–132 (2016)
M. Park, H.J. Yoon, M.C. Kang, J. Kwon, H.W. Lee, MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Sci. Rep. 7, 10932 (2017)
H. Su, F. Lin, X. Deng, L. Shen, Y. Fang, Z. Fei, L. Zhao, X. Zhang, H. Pan, D. Xie, X. Jin, C. Xie, Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells. J. Transl. Med. 14, 225 (2016)
C. Li, L.X. Wang, Chemoenzymatic methods for the synthesis of glycoproteins. Chem. Rev. 118, 8359–8413 (2018)
B.N. Vajaria, P.S. Patel, Glycosylation: a hallmark of cancer? Glycoconj. J. 34, 147–156 (2017)
S.R. Stowell, T. Ju, R.D. Cummings, Protein glycosylation in cancer. Annu. Rev. Pathol. 10, 473–510 (2015)
C. Jaillet, W. Morelle, M.C. Slomianny, V. Paget, G. Tarlet, V. Buard, S. Selbonne, F. Caffin, E. Rannou, P. Martinez, A. Francois, F. Foulquier, F. Allain, F. Milliat, O. Guipaud, Radiation-induced changes in the glycome of endothelial cells with functional consequences. Sci. Rep. 7, 5290 (2017)
E. Toth, K. Vekey, O. Ozohanics, A. Jeko, I. Dominczyk, P. Widlak, L. Drahos, Changes of protein glycosylation in the course of radiotherapy. J. Pharm. Biomed. Anal. 118, 380–386 (2016)
C. Huang, M. Huang, W. Chen, W. Zhu, H. Meng, L. Guo, T. Wei, J. Zhang, N-acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial-mesenchymal transition. FEBS J. 282, 4295–4306 (2015)
X. Dong, Z. Luo, Y. Wang, L. Meng, Q. Duan, L. Qiu, F. Peng, L. Shen, Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma. Exp. Cell Res. 362, 302–310 (2018)
M. Baro, C. Lopez Sambrooks, A. Quijano, W.M. Saltzman, J. Contessa, Oligosaccharyltransferase inhibition reduces receptor tyrosine kinase activation and enhances glioma radiosensitivity. Clin. Cancer Res. 25, 784–795 (2019)
S. Mohanty, A. Tsiouris, Z. Hammoud, Glycomic expression in esophageal disease. Metabolites 2, 1004–1011 (2012)
A.M. Byrne, R. Sharma, G. Duggan, D. Kelleher, A. Long, Deoxycholic acid impairs glycosylation and fucosylation processes in esophageal epithelial cells. Glycobiology 22, 638–648 (2012)
C. Zhang, X. Deng, L. Qiu, F. Peng, S. Geng, L. Shen, Z. Luo, Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation. J. Cancer 9, 2666–2677 (2018)
S. Fry, B. Afrough, A. Leathem, M. Dwek, Lectin array-based strategies for identifying metastasis-associated changes in glycosylation. Methods Mol. Biol. 878, 267–272 (2012)
Y. Zhou, L. Chu, Q. Wang, W. Dai, X. Zhang, J. Chen, L. Li, P. Ding, L. Zhang, H. Gu, X. Lv, W. Zhang, D. Zhou, P. Zhang, G. Cai, K. Zhao, W. Hu, CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair. Cell Death Dis. 9, 887 (2018)
S. Wu, Z. Lv, Y. Wang, L. Sun, Z. Jiang, C. Xu, J. Zhao, X. Sun, X. Li, L. Hu, A. Tang, Y. Gui, F. Zhou, Z. Cai, R. Wang, Increased expression of pregnancy up-regulated non-ubiquitous calmodulin kinase is associated with poor prognosis in clear cell renal cell carcinoma. PLoS One 8, e59936 (2013)
L. Xie, X. Song, J. Yu, L. Wei, B. Song, X. Wang, L. Lv, Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J. Exp. Clin. Cancer Res. 28, 68 (2009)
S.M. Zhou, L. Cheng, S.J. Guo, Y. Wang, D.M. Czajkowsky, H. Gao, X.F. Hu, S.C. Tao, Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer. Breast Cancer Res. 17, 36 (2015)
L. Yang, Z. Yang, L. Cheng, J. Cheng, Y. Sun, W. Li, K. Song, W. Huang, Y. Yin, S. Tao, Q. Zhang, Lectin microarray combined with mass spectrometry identifies haptoglobin-related protein (HPR) as a potential serologic biomarker for separating nonbacterial pneumonia from bacterial pneumonia in childhood. Proteomics Clin. Appl. 12, e1800030 (2018)
X.L. Yang, H.Y. Li, Y.Z. Yue, W.J. Ding, C. Xu, T.T. Shi, G.W. Chen, L.G. Wang, Transcriptomic analysis of the candidate genes related to aroma formation in osmanthus fragrans. Molecules 23, 1604 (2018)
B. He, Z. Hu, L. Ma, H. Li, M. Ai, J. Han, B. Zeng, Transcriptome analysis of different growth stages of Aspergillus oryzae reveals dynamic changes of distinct classes of genes during growth. BMC Microbiol. 18, 12 (2018)
L. Shen, Q. Ke, J. Chai, C. Zhang, L. Qiu, F. Peng, X. Deng, Z. Luo, PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3. Exp. Cell Res. 370, 127–136 (2018)
W. Lin, J. Xie, N. Xu, L. Huang, A. Xu, H. Li, C. Li, Y. Gao, M. Watanabe, C. Liu, P. Huang, Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells. Int. J. Biol. Sci. 14, 418–426 (2018)
X. Dong, Z. Luo, T. Liu, J. Chai, Q. Ke, L. Shen, Identification of integrin β1 as a novel PAG1-interacting protein involved in the inherent radioresistance of human laryngeal carcinoma. J. Cancer 9, 4128–4138 (2018)
P. Agrawal, B. Fontanals-Cirera, E. Sokolova, S. Jacob, C.A. Vaiana, D. Argibay, V. Davalos, M. McDermott, S. Nayak, F. Darvishian, M. Castillo, B. Ueberheide, I. Osman, D. Fenyo, L.K. Mahal, E. Hernando, A systems biology approach identifies FUT8 as a driver of melanoma metastasis. Cancer Cell 31, 804–819:e807 (2017)
S. Ishihara, M. Yasuda, A. Ishizu, M. Ishikawa, H. Shirato, H. Haga, Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget 6, 4602–4614 (2015)
M. Aco-Tlachi, R. Carreno-Lopez, P.L. Martinez-Morales, P. Maycotte, A. Aguilar-Lemarroy, L.F. Jave-Suarez, G. Santos-Lopez, J. Reyes-Leyva, V. Vallejo-Ruiz, Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes. Infect. Agent. Cancer 13, 25 (2018)
S. Yanagidani, N. Uozumi, Y. Ihara, E. Miyoshi, N. Yamaguchi, N. Taniguchi, Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-β-D-glucosaminide:α1–6 fucosyltransferase (α1–6 FucT) from human gastric cancer MKN45 cells. J. Biochem. 121, 626–632 (1997)
X. Ju, S. Liang, J. Zhu, G. Ke, H. Wen, X. Wu, Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA Double-strand Breaks (DSBs). Am. J. Transl. Res. 8, 2498–2511 (2016)
B.G. Ng, G. Xu, N. Chandy, J. Steyermark, D.N. Shinde, K. Radtke, K. Raymond, C.B. Lebrilla, A. AlAsmari, S.F. Suchy, Z. Powis, E.A. Faqeih, S.A. Berry, D.F. Kronn, H.H. Freeze, Biallelic mutations in FUT8 cause a congenital disorder of glycosylation with defective fucosylation. Am. J. Hum. Genet. 102, 188–195 (2018)
P. Dana, S. Saisomboon, R. Kariya, S. Okada, S. Obchoei, K. Sawanyawisuth, C. Wongkham, C. Pairojkul, S. Wongkham, K. Vaeteewoottacharn, CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-kappaB pathway promotes cholangiocarcinoma migration and invasion. Cell. Oncol. 43, 211–222 (2020)
F. Peng, H. Li, Q. You, D. Wu, C. Jiang, G. Deng, Y. Li, Y. Wu, CD147 as a novel prognostic biomarker for hepatocellular carcinoma: a meta-analysis. Biomed. Res. Int. 2017, 5019367 (2017)
H. Li, Z. Xi, X. Dai, W. Wu, Y. Li, Y. Liu, H. Zhang, CD147 and glioma: a meta-analysis. J. Neurooncol. 134, 145–156 (2017)
H. Li, D. Wu, S. Shi, Y. Xu, L. Wei, J. Liu, Y. Liu, Expression and clinical significance of CD147 in renal cell carcinoma: a meta-analysis.Oncotarget 8, 51331–51344 (2017)
H. Li, C. Jiang, D. Wu, S. Shi, M. Liao, J. Wang, Y. Li, Z. Xu, The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: a meta-analysis. PLoS One 12, e0180271 (2017)
Y. Zhao, J. Yi, L. Tao, G. Huang, X. Chu, H. Song, L. Chen, Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma. Cell Death Dis. 9, 433 (2018)
H. Ma, S. Zheng, X. Zhang, T. Gong, X. Lv, S. Fu, S. Zhang, X. Yin, J. Hao, C. Shan, S. Huang, High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy. Cell Death Dis. 10, 136 (2019)
C.F. Tu, M.Y. Wu, Y.C. Lin, R. Kannagi, R.B. Yang, FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. Breast Cancer Res. 19, 111 (2017)
L. Cheng, S. Gao, X. Song, W. Dong, H. Zhou, L. Zhao, L. Jia, Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Oncotarget 7, 61199–61214 (2016)
Y. Ito, A. Miyauchi, H. Yoshida, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, N. Taniguchi, N. Matsuura, K. Kuma, E. Miyoshi, Expression of α1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. Cancer Lett. 200, 167–172 (2003)
C. Li, S. Zhu, C. Ma, L.X. Wang, Designer α1,6-fucosidase mutants enable direct core fucosylation of intact N-Glycopeptides and N-Glycoproteins. J. Am. Chem. Soc. 139, 15074–15087 (2017)
X. Lv, J. Song, K. Xue, Z. Li, M. Li, D. Zahid, H. Cao, L. Wang, W. Song, T. Ma, J. Gu, W. Li, Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake. Mol. Carcinog. 58, 794–807 (2019)
Y. Bai, W. Huang, L.T. Ma, J.L. Jiang, Z.N. Chen, Importance of N-glycosylation on CD147 for its biological functions. Int. J. Mol. Sci. 15, 6356–6377 (2014)
J. Cui, W. Huang, B. Wu, J. Jin, L. Jing, W.P. Shi , Z.Y. Liu, L. Yuan, D. Luo, L. Li, Z.N. Chen, J.L. Jiang, N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147/basigin with integrin β1 and promotes HCC metastasis. J. Pathol. 245, 41–52 (2018)
W. Huang, W.J. Luo, P. Zhu, J. Tang, X.L. Yu, H.Y. Cui, B. Wang, Y. Zhang, J.L. Jiang, Z.N. Chen, Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem. J. 449, 437–448 (2013)
L. Li, X. Dong, F. Peng, L. Shen, Integrin β1 regulates the invasion and radioresistance of laryngeal cancer cells by targeting CD147. Cancer Cell Int. 18, 80 (2018)
J. Wu, Y. Li, Y.Z. Dang, H.X. Gao, J.L. Jiang, Z.N. Chen, HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling. Mol. Cancer Ther. 14, 553–563 (2015)
Acknowledgements
We thank American Journal Experts (AJE) for English language editing.
Funding
This study was funded by the National Natural Science Foundation of China (NO. 81502666, NO. 81902494), the Natural Science Foundation of Hubei Province (NO.2019CFA034, NO. 2019CFB441), the Initial Project for Post-Graduates of the Hubei University of Medicine (NO.2016QDJZR10), the Free Exploration Foundation of the Hubei University of Medicine (NO.FDFR201802), and the Innovation Project for graduates of the Hubei University of Medicine (NO. YC2019007).
Author information
Authors and Affiliations
Contributions
Li Shen and Min Xia designed the study and performed the experiments. Xinzhou Deng, Qing Ke, Chuanyi Zhang and Feng Peng collected and analysed the data. Xiaoxia Dong and Zhiguo Luo prepared the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Informed consent was obtained from all patients enrolled in the present study. This study was approved by the Ethics Committee of the Hubei University of Medicine (Hubei, China). All animal experiments were performed according to protocols approved by the Committee on Animal Welfare of the Hubei University of Medicine.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shen, L., Xia, M., Deng, X. et al. A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma. Cell Oncol. 43, 695–707 (2020). https://doi.org/10.1007/s13402-020-00517-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-020-00517-5